Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of BEPO-A vs REPO-A (Espogen) in Healthy Males
NCT02426151Phase 1Completed
- Sponsor
- LG Chem
- Start
- Apr 2015
- Primary completion
- May 2015
- Modality
- Biologic, rProtein (Recombinant Protein)
01
Overview
Phase 1, randomised, open-label trial of epoetin alfa in anemia (2 arms), sponsored by LG Chem. Primary endpoints: Maximum Plasma Concentration at 14 hours and Area Under the Curve to Last Measurable Concentration at 14 hours. Started Apr 2015; status: completed.
02
Drugs
epoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT02426151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02426151.